1479-6694
Monthly
No
FUTURE ONCOL
2005
223
ENGLAND
http://www.futuremedicine.com/loi/fon
偏慢,4-8周審稿時間
2.279影響因子
腫瘤學(xué)小學(xué)科
我們已經(jīng)看到并將繼續(xù)看到腫瘤學(xué)領(lǐng)域的巨大變化。雖然疾病負擔(dān)將增加,但腫瘤學(xué)家可用的醫(yī)療設(shè)備將更大、更堅固,并有可能專注于個人需求。未來腫瘤學(xué)(ISSN1479-6694)為癌癥治療的新時代提供了一個論壇。該雜志關(guān)注最重要的進展,并強調(diào)其在臨床環(huán)境中的相關(guān)性。此外,未來腫瘤學(xué)以簡潔、一目了然的文章格式提供基本信息,這對于向時間日益有限的社區(qū)提供信息至關(guān)重要。該雜志對科學(xué)和臨床問題,以及經(jīng)濟、政策和現(xiàn)實世界問題采取了前瞻性的立場,我們在這個癌癥治療的新時代所面臨的問題。該雜志包括文獻意識,如放射治療和免疫治療的最新進展,簡明的評論和分析,以及全面的評論文章,所有這些都提供了關(guān)鍵的發(fā)現(xiàn),轉(zhuǎn)化為臨床環(huán)境。討論的主題包括:新型抗癌劑概況正在進行的研究的方案選擇性和“個性化”方法新免疫療法、放射療法和生物標志物的臨床意義和應(yīng)用診斷和治療方法的整合分子遺傳學(xué)對預(yù)防、篩選、診斷和治療的影響篩選方案和方法癌癥的生物學(xué)過程以及新的認識將如何影響治療關(guān)于政策和治療指南的當(dāng)前辯論現(xiàn)實數(shù)據(jù)和結(jié)果研究該雜志歡迎不請自來的文章建議。
http://www.futuremedicine.com/page/submitarticle
We have seen and will continue to see dramatic changes within the field of oncology. Whilst the burden of disease is set to increase, the available armamentarium to the oncologist will be greater, more robust and offer the potential to focus on individual needs. Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community.The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic, policy and real world issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting. Topics addressed include:Profiles of new anticancer agentsProtocols of on-going studies Selective and 'personalized' approachesClinical implications and applications for new immunotherapies, radiotherapies and biomarkersIntegration of diagnostic and therapeutic approachesImpact of molecular genetics on prevention, screening, diagnosis and treatmentScreening programs and methodologyBiological processes involved in cancer and how new understanding will impact treatmentCurrent debates on policy and treatment guidelinesReal world data and outcomes research The journal welcomes unsolicited article proposals.
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評審,對文章進行評價;
立即咨詢校對編輯、深度潤色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標準;
立即咨詢適用于語句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達到要求;
立即咨詢數(shù)據(jù)庫包括:期刊、文章、書籍、會議、預(yù)印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標期刊格式要求對作者文章進行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA ONCOLOGICA | 醫(yī)學(xué) | 腫瘤學(xué) | 3.298 | 3區(qū) | 0284-186X |
Advances in Cancer Research | 醫(yī)學(xué) | 腫瘤學(xué) | 4.667 | N/A | 0065-230X |
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 醫(yī)學(xué) | 腫瘤學(xué) | 3.015 | N/A | 0277-3732 |
ANNALS OF ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 14.196 | N/A | 0923-7534 |
ANNALS OF SURGICAL ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 3.681 | N/A | 1068-9265 |
ANTI-CANCER DRUGS | 醫(yī)學(xué) | 腫瘤學(xué) | 1.801 | N/A | 0959-4973 |
ANTICANCER RESEARCH | 醫(yī)學(xué) | 腫瘤學(xué) | 1.935 | N/A | 0250-7005 |
Asia-Pacific Journal of Clinical Oncology | 醫(yī)學(xué) | 腫瘤學(xué) | 1.539 | N/A | 1743-7555 |
BMC CANCER | 醫(yī)學(xué) | 腫瘤學(xué) | 2.933 | N/A | 1471-2407 |
Brachytherapy | 醫(yī)學(xué) | 腫瘤學(xué) | 2.03 | 4區(qū) | 1538-4721 |
發(fā)現(xiàn)心儀選題請?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊